BIOTON S.A.

Warsaw Stock Exchange BIO.WA

BIOTON S.A. EBITDA for the year ending December 31, 2023: USD 11.13 M

BIOTON S.A. EBITDA is USD 11.13 M for the year ending December 31, 2023, a -16.71% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

BIOTON S.A. EBITDA for the year ending December 31, 2022 was USD 13.37 M, a 19.82% change year over year.
BIOTON S.A. EBITDA for the year ending December 31, 2021 was USD 11.15 M, a -45.37% change year over year.
BIOTON S.A. EBITDA for the year ending December 31, 2020 was USD 20.42 M, a 162.31% change year over year.
BIOTON S.A. EBITDA for the year ending December 31, 2019 was USD -32.77 M, a -332.95% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Warsaw Stock Exchange: BIO.WA

BIOTON S.A.

CEO	Mr. Jeremy Launders
IPO Date	March 31, 2005
Location	Poland
Headquarters	ul. Poznanska 12
Employees	355
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care

Description

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.

Key trends

Past 5 years